Russia’s RDI Direct Investment Fund and China’s Shenzhen Yuanxing Gene-tech have agreed to produce more than 60 million doses of Russia’s Sputnik V vaccine against COVID-19 in China, the RDIF said on Monday.
RFDI, which markets Sputnik V around the world, said that commercial production should begin in May – according to Reuters.
Full publication (reprint) of dip.org.ua materials on social networks is prohibited. Partial reprinting (up to 30% of the material) is possible if there is an active hyperlink to the source of the publication and a clickable link to the page dip.org.ua on social networks at the beginning of the post.
When using dip.org.ua materials on other Internet sites, a direct active hyperlink to the page containing the original publication is mandatory. The link should be visible and located at the beginning of the publication. Otherwise we will swear.
The site may contain content that is not suitable for viewing by people under 16 years of age.
© 2022 DIP - Tourist portal
